Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Edward Dudek
University of Utah, Department: Physiology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Epitel, Inc.
Payment for services (e.g., consulting fees, honoraria, paid authorship)
This research project will use the Epitel miniature telemetry system for long-term monitoring of the spontaneous seizures that are the key outcome measure for the epileptic animals. Dr. Dudek has a consulting relationship and an equity interest in the company that makes the device/system. The telemetry system will be made available to the lab for this project at cost, and the device will be tested in these experiments.
Ivermectin and human glycine receptor suppression of pharmacoresistant epilepsy
An enormous challenge in the clinical treatment of epilepsy is that 30-40% of the people with epilepsy continue to have seizures in spite of many newly-discovered antiepileptic drugs. We propose to develop a novel system for treating this pharmacoresistant epilepsy that will involve a gene-therapy approach based on novel 'designer' receptors and a novel FDA- approved drug that should produce minimal effects on the normal brain. Successful completion of these studies is intended to lead directly to clinical trials for te treatment of pharmacoresistant epilepsy patients.
Filed on July 29, 2013.
Tell us what you know about Edward Dudek's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Edward Dudek filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Edward Dudek | University of Utah | Conflict of Interest | Epitel, Inc. | Value cannot be readily determined |
Other search results for: “Edward Dudek”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Edward Dudek | University of Utah | Conflict of Interest | Epitel | Value cannot be determined |
| Edward Dudek | University of Utah | Conflict of Interest | Rugen | $5,000-9,999 |
| Edward Dudek | University of Utah | Conflict of Interest | Epitel | Value cannot be determined |
| Edward Dudek | University of Utah | Conflict of Interest | Epitel | $20,000-39,999 |
| Edward Dudek | University of Utah | Conflict of Interest | Epitel | Value cannot be determined |
| Edward Dudek | University of Utah | Conflict of Interest | Rugen | $5,000-9,999 |
| Edward Dudek | University of Utah | Conflict of Interest | Rugen | $5,000-9,999 |
| Edward Dudek | University of Utah | Conflict of Interest | Epitel | $20,000-39,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.